We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 13, 2020

Safety of Concurrent CDK4/6 Inhibitors and Radiation Therapy in Patients With Metastatic Breast Cancer

Scientific reports

 

Additional Info

Scientific reports
A Single-Center Retrospective Safety Analysis of Cyclin-Dependent Kinase 4/6 Inhibitors Concurrent With Radiation Therapy in Metastatic Breast Cancer Patients
Sci Rep 2020 Aug 12;[EPub Ahead of Print], AE Guerini, S Pedretti, E Salah, EL Simoncini, M Maddalo, L Pegurri, R Pedersini, L Vassalli, N Pasinetti, G Peretto, L Triggiani, G Costantino, V Figlia, F Alongi, SM Magrini, M Buglione

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading